8,103 results on '"Sleep Apnea, Obstructive therapy"'
Search Results
2. Con: can comparing adherent to non-adherent patients provide useful estimates of the effect of continuous positive airway pressure?
- Author
-
Patel SR, Sawyer AM, and Gottlieb DJ
- Subjects
- Humans, Treatment Outcome, Continuous Positive Airway Pressure methods, Sleep Apnea, Obstructive therapy, Patient Compliance statistics & numerical data
- Published
- 2024
- Full Text
- View/download PDF
3. Uncovering the effect of CPAP on cardiovascular outcomes in obstructive sleep apnea.
- Author
-
Singh B and Mazzotti DR
- Subjects
- Humans, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Continuous Positive Airway Pressure methods, Cardiovascular Diseases
- Published
- 2024
- Full Text
- View/download PDF
4. Community-based intervention for obstructive sleep apnea in the general population: a randomized controlled trial.
- Author
-
Wang L, Ou Q, Shan G, Zhan W, Huang J, Lin Q, Li J, Liu Y, Xu Y, Chen C, and Chen W
- Subjects
- Humans, Male, Female, Middle Aged, China, Adult, Polysomnography, Sleep Apnea, Obstructive therapy, Quality of Life, Continuous Positive Airway Pressure methods
- Abstract
Study Objectives: To investigate the engagement and health outcomes of community-based intervention for obstructive sleep apnea (OSA) in the general population., Methods: We conducted a 3-month randomized controlled trial in two communities in southern China. We initially screened the general population for high-risk OSA and further diagnosis using home sleep testing. Eligible participants were randomly (1:1) assigned to either a control or continuous positive airway pressure-based integrated intervention group. The primary outcomes were multimodal indicators reflecting health outcomes, including health-related quality of life (Short Form-36 [SF-36]), sleep-related symptoms, and cardiometabolic risk., Results: Of the 2484 participants screened, 1423 identified as having high-risk OSA were considered for telephone invitations to participate in the trial. Of these, 401 participants responded positively (28.2%), 279 were diagnosed with OSA, and 212 were randomized. The intervention significantly improved several domains of SF-36, including physical functioning (intergroup difference, 2.8; p = .003), vitality (2.3; p = .031), and reported health transition (6.8; p = .005). Sleep-related symptoms, including Epworth Sleepiness Scale (-0.7; p = .017), Fatigue Severity Scale (-3.0; p = .022), Insomnia Severity Index (-1.8; p < .001), and Pittsburgh Sleep Quality Index (-0.7; p = .032), also showed significant improvements. Although the intervention did not significantly alter glycolipid metabolism, ventricular function, or cardiac structural remodeling, it achieved a significant reduction in systolic (-4.5 mmHg; p = .004) and diastolic blood pressure (BP; -3.7 mmHg; p < .001)., Conclusions: Community-based intervention for previously undiagnosed OSA in the general population yielded improvements in health-related quality of life, sleep-related symptoms, and BP. However, engagement in the intervention program was low., Clinical Trial Registration: "Community Intervention Trial for OSA";URL: https://www.chictr.org.cn/showprojEN.html?proj=144927;Trial identification number: ChiCTR2100054800., (© The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
5. Mask side-effects are related to gender in long-term CPAP: results from the InterfaceVent real-life study.
- Author
-
Vidal C, Bertelli F, Mallet JP, Gilson R, Borel JC, Gagnadoux F, Bourdin A, Molinari N, and Jaffuel D
- Subjects
- Humans, Female, Male, Middle Aged, Prospective Studies, Cross-Sectional Studies, Aged, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive epidemiology, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive physiopathology, Time Factors, Adult, Sex Factors, Patient Compliance, Cohort Studies, Sex Characteristics, Continuous Positive Airway Pressure adverse effects, Masks adverse effects
- Abstract
Background: Over the past three decades, our understanding of sleep apnea in women has advanced, revealing disparities in pathophysiology, diagnosis, and treatment compared to men. However, no real-life study to date has explored the relationship between mask-related side effects (MRSEs) and gender in the context of long-term CPAP., Methods: The InterfaceVent-CPAP study is a prospective real-life cross-sectional study conducted in an apneic adult cohort undergoing at least 3 months of CPAP with unrestricted mask-access (34 different masks, no gender specific mask series). MRSE were assessed by the patient using visual analog scales (VAS). CPAP-non-adherence was defined as a mean CPAP-usage of less than 4 h per day. The primary objective of this ancillary study was to investigate the impact of gender on the prevalence of MRSEs reported by the patient. Secondary analyses assessed the impact of MRSEs on CPAP-usage and CPAP-non-adherence depending on the gender., Results: A total of 1484 patients treated for a median duration of 4.4 years (IQ
25-75 : 2.0-9.7) were included in the cohort, with women accounting for 27.8%. The prevalence of patient-reported mask injury, defined as a VAS score ≥ 5 (p = 0.021), was higher in women than in men (9.6% versus 5.3%). For nasal pillow masks, the median MRSE VAS score for dry mouth was higher in women (p = 0.039). For oronasal masks, the median MRSE VAS score for runny nose was higher in men (p = 0.039). Multivariable regression analyses revealed that, for both women and men, dry mouth was independently and negatively associated with CPAP-usage, and positively associated with CPAP-non-adherence., Conclusion: In real-life patients treated with long-term CPAP, there are gender differences in patient reported MRSEs. In the context of personalized medicine, these results suggest that the design of future masks should consider these gender differences if masks specifically for women are developed. However, only dry mouth, a side effect not related to mask design, impacts CPAP-usage and non-adherence., Trial Registration: INTERFACEVENT IS REGISTERED WITH CLINICALTRIALS.GOV (NCT03013283).FIRST REGISTRATION DATE IS 2016-12-23., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
6. Positive Airway Pressure, Mortality, and Cardiovascular Risk in Older Adults With Sleep Apnea.
- Author
-
Mazzotti DR, Waitman LR, Miller J, Sundar KM, Stewart NH, Gozal D, and Song X
- Subjects
- Humans, Female, Male, Aged, Retrospective Studies, United States epidemiology, Aged, 80 and over, Incidence, Heart Disease Risk Factors, Cardiovascular Diseases mortality, Cardiovascular Diseases epidemiology, Continuous Positive Airway Pressure, Sleep Apnea, Obstructive mortality, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Medicare statistics & numerical data
- Abstract
Importance: Positive airway pressure (PAP) is the first-line treatment for obstructive sleep apnea (OSA), but evidence on its beneficial effect on major adverse cardiovascular events (MACE) and mortality prevention is limited., Objective: To determine whether PAP initiation and utilization are associated with lower mortality and incidence of MACE among older adults with OSA living in the central US., Design, Setting, and Participants: This retrospective clinical cohort study included Medicare beneficiaries with 2 or more distinct OSA claims identified from multistate, statewide, multiyear (2011-2020) Medicare fee-for-service claims data. Individuals were followed up until death or censoring on December 31, 2020. Analyses were performed between December 2021 and December 2023., Exposures: Evidence of PAP initiation and utilization based on PAP claims after OSA diagnosis., Main Outcomes and Measures: All-cause mortality and MACE, defined as a composite of myocardial infarction, heart failure, stroke, or coronary revascularization. Doubly robust Cox proportional hazards models with inverse probability of treatment weights were used to estimate treatment effect sizes controlling for sociodemographic and clinical factors., Results: Among 888 835 beneficiaries with OSA included in the analyses (median [IQR] age, 73 [69-78] years; 390 598 women [43.9%]; 8115 Asian [0.9%], 47 122 Black [5.3%], and 760 324 White [85.5%] participants; median [IQR] follow-up, 3.1 [1.5-5.1] years), those with evidence of PAP initiation (290 015 [32.6%]) had significantly lower all-cause mortality (hazard ratio [HR], 0.53; 95% CI, 0.52-0.54) and MACE incidence risk (HR, 0.90; 95% CI, 0.89-0.91). Higher quartiles (Q) of annual PAP claims were progressively associated with lower mortality (Q2 HR, 0.84; 95% CI, 0.81-0.87; Q3 HR, 0.76; 95% CI, 0.74-0.79; Q4 HR, 0.74; 95% CI, 0.72-0.77) and MACE incidence risk (Q2 HR, 0.92; 95% CI, 0.89-0.95; Q3 HR, 0.89; 95% CI, 0.86-0.91; Q4 HR, 0.87; 95% CI, 0.85-0.90)., Conclusions and Relevance: In this cohort study of Medicare beneficiaries with OSA, PAP utilization was associated with lower all-cause mortality and MACE incidence. Results might inform trials assessing the importance of OSA therapy toward minimizing cardiovascular risk and mortality in older adults.
- Published
- 2024
- Full Text
- View/download PDF
7. CPAP-Beatmung lindert auch Hypertonie.
- Author
-
Büchner N
- Subjects
- Humans, Continuous Positive Airway Pressure, Hypertension therapy, Sleep Apnea, Obstructive therapy
- Published
- 2024
- Full Text
- View/download PDF
8. Advances in Sleep-Disordered Breathing in Children.
- Author
-
Gileles-Hillel A, Bhattacharjee R, Gorelik M, and Narang I
- Subjects
- Humans, Child, Continuous Positive Airway Pressure, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive physiopathology, Adenoidectomy, Polysomnography, Tonsillectomy, Sleep Apnea Syndromes therapy, Sleep Apnea Syndromes diagnosis, Sleep Apnea Syndromes physiopathology, Sleep Apnea Syndromes complications
- Abstract
Pediatric sleep-disordered breathing disorders are a group of common conditions, from habitual snoring to obstructive sleep apnea (OSA) syndrome, affecting a significant proportion of children. The present article summarizes the current knowledge on diagnosis and treatment of pediatric OSA focusing on therapeutic and surgical advancements in the field in recent years. Advancements in OSA such as biomarkers, improving continuous pressure therapy adherence, novel pharmacotherapies, and advanced surgeries are discussed., Competing Interests: Disclosure None., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Device-related outcomes following hypoglossal nerve stimulator implantation.
- Author
-
Moroco AE, Wei Z, Byrd I, Rasmussen A, Chio EG, Soose RJ, Huyett P, Steffen A, Heiser C, Boon MS, and Huntley CT
- Subjects
- Humans, Male, Female, Middle Aged, Reoperation statistics & numerical data, Treatment Outcome, Device Removal methods, Device Removal statistics & numerical data, Product Surveillance, Postmarketing statistics & numerical data, Adult, Implantable Neurostimulators adverse effects, Hypoglossal Nerve surgery, Electric Stimulation Therapy methods, Electric Stimulation Therapy instrumentation, Electric Stimulation Therapy adverse effects, Sleep Apnea, Obstructive therapy
- Abstract
Study Objectives: Hypoglossal nerve stimulation (HGNS) has been widely used to treat obstructive sleep apnea in selected patients. Here we evaluate rates of revision and explant related to HGNS implantation and assess types of adverse events contributing to revision and explant., Methods: Postmarket surveillance data for HGNS implanted between January 1, 2018 and March 31, 2022, were collected. Event rates and risk were calculated using the postmarket surveillance event counts and sales volume over the same period. Indications were categorized for analysis. Descriptive statistics were reported and freedom from explant or revision curves were grouped by year of implantation., Results: Of the 20,881 HGNS implants assessed, rates of explant and revision within the first year were 0.723% and 1.542%, respectively. The most common indication for explant was infection (0.378%) and for revision was surgical correction (0.680%). Of the 5,820 devices with 3-year postimplantation data, the rate of explant was 2.680% and of revision was 3.557%. During this same interval, elective removal (1.478%) was the most common indication, and for revisions, surgical correction (1.134%)., Conclusions: The efficacy of HGNS is comparable in the real world setting to published clinical trial data. Rates of explant and revision are low, supporting a satisfactory safety profile for this technology., Citation: Moroco AE, Wei Z, Byrd I, et al. Device-related outcomes following hypoglossal nerve stimulator implantation. J Clin Sleep Med . 2024;20(9):1497-1503., (© 2024 American Academy of Sleep Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
10. Comparative analysis of pain outcomes in hypoglossal nerve stimulation: Avoiding the digastric tendon.
- Author
-
Ho B, Nguyen BK, and Tomovic S
- Subjects
- Humans, Female, Male, Middle Aged, Retrospective Studies, Treatment Outcome, Aged, Tendons surgery, Adult, Patient Satisfaction, Hypoglossal Nerve surgery, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive surgery, Electric Stimulation Therapy methods, Pain, Postoperative prevention & control, Pain, Postoperative etiology
- Abstract
Objective: Upper airway stimulation effectively treats patients with obstructive sleep apnea, especially among those with low long-term compliance with continuous positive airway pressure. Traditional methods to implant the hypoglossal nerve stimulator involve retraction of the digastric tendon to identify the nerve and improve exposure for stimulator implantation. Transient submental pain and discomfort are known side effects of the procedure. Placement without retraction provides an alternative approach to minimize postoperative pain. This study compares post-operative pain outcomes of patients in whom the digastric tendon was and was not retracted., Methods: Retrospective chart review of patients who received the hypoglossal nerve stimulation implant at a single institution between 2017 and 2021. A combination of descriptive and qualitative data, including age, gender, comorbidities, and postoperative symptoms are analyzed to characterize patient outcomes resulting from this intraoperative technique. The categorical and continuous variables were analyzed using chi-squared tests and independent t-tests, respectively., Results: Patients report overall satisfaction after implantation and titration. A total of 108 patients underwent HGNS implantation between September 2017 and January 2021 using the aforementioned techniques. 1.69 % of patients experienced postoperative submental pain as compared to 18.37 % prior to the change in technique (p < 0.01)., Conclusion: Avoidance of digastric tendon retraction in the implantation of the stimulating lead is a safe and effective technique that reduces postoperative pain and discomfort. Our institution has demonstrated an alternative technique for hypoglossal stimulator implantation which improves perioperative outcomes., Lay Summary: Upper airway stimulation is an effective treatment for obstructive sleep apnea. During surgery, the digastric tendon is often moved to identify the nerve and improve access. This study shows that avoiding digastric tendon movement safely reduces postoperative pain and discomfort., Level of Evidence: III., Competing Interests: Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Circuit-dependent carbon dioxide rebreathing during continuous positive airway pressure.
- Author
-
Messineo L, Hete B, Diesem R, and Noah W
- Subjects
- Humans, Respiratory Rate physiology, Carbon Dioxide, Continuous Positive Airway Pressure instrumentation, Continuous Positive Airway Pressure methods, Sleep Apnea, Obstructive therapy, Tidal Volume physiology, Masks
- Abstract
Background: The current standard treatment for obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP), is characterized by a low adherence rate due to various factors including circuit-dependent carbon dioxide (CO
2 ) rebreathing, which can exacerbated by disparate factors, such as low PAP, use of auto-titrating PAP or ramps. However, risk factors for rebreathing are often overlooked or poorly understood in clinical practice. Therefore, our objective was to evaluate the extent of rebreathing occurring with commonly used CPAP masks across varying PAPs, tidal volumes, and respiratory rates., Methods: In a bench study, we assessed the rebreathing rate of nine masks interfacing a CPAP with a lung simulator providing different breathing respiratory rates (15 or 20 breaths/min) and tidal volumes (400, 500, 600, 700 and 750 mL). Additionally, a theoretical model was developed to describe the likelihood of CO2 rebreathing from four different masks at various breathing settings., Results: Overall, all masks performed worse in situations characterized by low PAPs, high tidal volumes, and high respiratory rates. However, Dreamwear, Nuance, Siesta, Vitera, and particularly V2 masks exhibited greater susceptibility to rebreathing compared to F20, P10, Brevida, and Rio masks for the same variations of PAPs or ventilatory parameters. The mathematical model suggested that the risk of rebreathing for Rio, P10 and Nuance mask is negligible for respiratory rates of 10 breaths/min or below., Conclusions: Circuit-dependent CO2 rebreathing can be a common occurrence and warrants careful mask selection upon CPAP therapy initiation for optimal clinical outcomes., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ryan Diesem reports financial support was provided by SleepRes. William Noah reports a relationship with SleepRes that includes: equity or stocks. Bernard Hete reports a relationship with SleepRes that includes: equity or stocks. William Noah has patent pending to SleepRes. Bernard Hete has patent pending to SleepRes. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
12. Exploring the Role of Testosterone in the Differential Outcomes of Continuous Positive Airway Pressure and Glucagon-like peptide 1 Treatments in Obstructive Sleep Apnea.
- Author
-
Lin YH, Wang TY, and Wu CT
- Subjects
- Humans, Male, Middle Aged, Treatment Outcome, Female, Sleep Apnea, Obstructive therapy, Continuous Positive Airway Pressure, Testosterone therapeutic use, Testosterone blood, Glucagon-Like Peptide 1
- Published
- 2024
- Full Text
- View/download PDF
13. Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome: An Update on the Epidemiology, Pathophysiology, and Management.
- Author
-
Nguyen BHM, Murphy PB, and Yee BJ
- Subjects
- Humans, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive epidemiology, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive complications, Pulmonary Disease, Chronic Obstructive therapy, Pulmonary Disease, Chronic Obstructive epidemiology, Pulmonary Disease, Chronic Obstructive physiopathology
- Abstract
This review provides an up-to-date summary of the prevalence, pathophysiology, diagnosis, and treatment of the chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) overlap syndrome (OVS). The presence of OVS is high in patients with COPD and in patients with OSA and is associated with profound nocturnal oxygen desaturation and systemic inflammation. There is a high prevalence of cardiovascular disease among patients with OVS and this likely contributes to increased mortality. Observational studies suggest that positive airway pressure therapy improves survival and reduces COPD exacerbations; however, randomized controlled trials will be required to confirm these findings., Competing Interests: Disclosure Dr P.B. Murphy reported receiving reimbursement for expenses for travel to conferences and lecture fees from Philips Respironics, ResMed, Fisher & Paykel, Chiesi, Genzyme and Breas Medical., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Psychometric Properties of the Turkish Version of Self-Efficacy Measure for Sleep Apnea (SEMSA) Instrument.
- Author
-
Alptekin G, Ciray N, Basoglu OK, and Weaver TE
- Subjects
- Humans, Male, Turkey, Female, Cross-Sectional Studies, Middle Aged, Surveys and Questionnaires, Reproducibility of Results, Adult, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive psychology, Translating, Factor Analysis, Statistical, Sleep Apnea Syndromes psychology, Psychometrics instrumentation, Psychometrics methods, Self Efficacy, Continuous Positive Airway Pressure psychology
- Abstract
Background: Determining the self-efficacy perceptions of obstructive sleep apnea (OSA) patients has a key role in health care practices. With further evaluation, the Self-Efficacy Measure for Sleep Apnea (SEMSA) could serve as a useful scale to develop specific interventions to increase self-efficacy in patients with OSA during the acceptance and maintenance of continuous positive airway pressure (CPAP) therapy., Objective: The aim of this study is to translate the SEMSA into Turkish and to evaluate the psychometric properties of the translation., Methods: This cross-sectional study was carried out with a sample of patients recently diagnosed with CPAP-naïve OSA. Linguistic and content validity of the scale were evaluated, while exploratory factor analysis and 2-level confirmatory factor analysis were used for validity. Internal consistency and test-retest methods were used in reliability analyses., Results: The mean (SD) age of the patients with OSA was 51.36 (11.29), and 68% were male. The item factor loads obtained as a result of the confirmatory factor analysis ranged from 0.44 to 0.94, confirming the three-factor structure of the instrument. The Cronbach's α coefficient of the scale was found to be 0.90. Measurements made within the scope of test-retest analysis were found to be related and consistent results were obtained in the intervening time ( P < .01)., Conclusions: In this study, the Turkish version of SEMSA was found to be a valid and reliable tool and it could be used to evaluate the adherence-related cognition in Turkish patients with OSA on CPAP therapy., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
15. Evaluating the impact of automatic positive airway pressure therapy on cardiovascular risk index and vascular behavior in patients with obstructive sleep apnea: a study on heterogeneity in the therapeutic response.
- Author
-
Zhu W, Xiang L, Cao L, Tian Y, Li W, and He L
- Subjects
- Humans, Male, Female, Middle Aged, Heart Disease Risk Factors, Photoplethysmography methods, Pulse Wave Analysis methods, Adult, Treatment Outcome, Polysomnography methods, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive complications, Continuous Positive Airway Pressure methods, Cardiovascular Diseases physiopathology
- Abstract
Study Objectives: This study investigated the impact of automatic positive airway pressure (APAP) therapy on vascular behavior and its potential to lower cardiovascular risk in patients with obstructive sleep apnea (OSA), as well as differentiating APAP therapy heterogeneity., Methods: All participants were diagnosed with OSA by portable monitoring, and pulse wave parameters and cardiac risk composite parameter index were obtained by photoplethysmography before and after APAP. Clustering analysis of pulse wave parameters before APAP in the high-risk population was performed using k-means clustering. Linear regression was used to assess the associations of changes in cardiac risk composite parameter index and pulse wave parameters with clinical characteristics., Results: Eighty-two patients with OSA underwent APAP therapy. The cardiac risk composite parameter index after APAP was significantly lower than before APAP (0.38 ± 0.33 and 0.58 ± 0.31, respectively; P < .001). All pulse wave parameters (except irregular pulse) were significantly different ( P < .001) in patients with OSA and in the high-risk responders group after vs before APAP. The differences in pulse wave parameters after vs before APAP were not significant in the high-risk nonresponders group, except for the difference between the pulse rate acceleration index and the oxygen saturation index and pulse rate variability. Four clusters were obtained from the clustering analysis of pulse wave parameters before APAP in the high-risk responders group., Conclusions: APAP reduces the cardiac risk composite parameter index in patients with OSA by altering vascular behavior. Overnight photoplethysmography monitoring of pulse wave parameters can be used to assess whether patients with OSA will benefit from APAP., Citation: Zhu W, Xiang L, Cao L, Tian Y, Li W, He L. Evaluating the impact of automatic positive airway pressure therapy on cardiovascular risk index and vascular behavior in patients with obstructive sleep apnea: a study on heterogeneity in the therapeutic response. J Clin Sleep Med . 2024;20(9):1435-1444., (© 2024 American Academy of Sleep Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
16. Stimulation of the internal superior laryngeal nerve as a potential therapy for obstructive sleep apnea in a porcine model.
- Author
-
Maurer JT, Huseynov J, Hochreiter J, and Perkins JD
- Subjects
- Animals, Swine, Disease Models, Animal, Electric Stimulation Therapy methods, Electric Stimulation methods, Pressure, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive therapy, Laryngeal Nerves physiopathology, Laryngeal Nerves physiology, Pharynx physiopathology, Pharynx innervation
- Abstract
Impaired pharyngeal sensing of negative pressure (NP) can lead to a blunted response of the upper airway dilator muscles and contribute to the development of obstructive sleep apnea (OSA). This response is modulated by the nerve fibers in the internal branch of the superior laryngeal nerve (iSLN), mediating negative pressure sensation. Artificial excitation of these fibers could be a potential treatment target for OSA. To evaluate this, electrostimulation of the iSLN was performed in a porcine-isolated upper airway model. Artificial obstructions were induced by varying the levels of negative pressure, and the ability of the animal to resolve these obstructions was evaluated. The pressure at which the animal was still able to resolve the obstruction was quantified as "Resolvable Pressure." Thereby, the effects on pharyngeal patency ( n = 35) and the duration of the therapeutic effect outlasting the stimulation ( n = 6) were quantified. Electrostimulation before the introduction of an artificial obstruction improved the median resolvable pressure from -28.3 cmH
2 O [IQR: -45.9; -26.1] to -92.6 cmH2 O [IQR: -105.1; -78.6]. The median therapeutic effect was found to outlast the last stimulation burst applied by 163 s when five stimulation bursts were applied in short succession [IQR: 58; 231], 58 s when two were applied [IQR: 7; 65], and 6 s when one was applied [IQR: 0; 51]. Stimulation of the iSLN increased electromyography (EMG) in the genioglossus (GG). The proposed treatment concept can improve pharyngeal patency in the model. Transfer of the results to clinical application could enable the development of a new neuromodulation therapy for OSA. NEW & NOTEWORTHY Electrostimulation before the introduction of an artificial obstruction to induce artificial sleep apnea in the pig model improves the response of the upper airway to negative pressure (NP). The electrostimulation creates a sustained therapeutic effect that outlasts the initial electrostimulation. The use of this therapy in clinical practice has the potential to treat obstructive sleep apnea (OSA).- Published
- 2024
- Full Text
- View/download PDF
17. Effects of high-intensity interval training on subjective sleep quality and daytime sleepiness in patients with obstructive sleep apnea: A secondary analysis from a randomized controlled trial.
- Author
-
Lins-Filho O, Aguiar JLP, Soares Germano AH, Vieira de Almeida JR, Felinto Dos Santos EC, Lyra MJ, Farah BQ, and Pedrosa RP
- Subjects
- Humans, Male, Female, Middle Aged, Disorders of Excessive Somnolence, Adult, Heart Rate physiology, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive complications, High-Intensity Interval Training methods, Sleep Quality
- Abstract
This study aimed to verify the effect of 12 weeks of HIIT on the perceived sleep quality and excessive daytime sleepiness in patients with obstructive sleep apnea (OSA). For this, a secondary analysis of a randomized controlled trial, including 36 adults with moderate-severe OSA (19 males; 52.2 ± 9.8 years; body mass index = 34.2 ± 5.8; AHI = 42.0 ± 22.9 e/h) was performed. Participants were randomly assigned to HIIT [5 periods of 4 min of walking or running on a treadmill at 90-95 % of maximum heart rate (HRmax) interspersed with 3 min of walking at 50-55 % of HRmax performed three times per week for 12 weeks] or a control group (CG; stretching exercises performed two times per week for 12 weeks). Specific domains of subjective sleep quality and EDS were assessed at baseline and post 12 weeks. Generalized estimated equation were used to verify between groups and times differences. There were no group × time interactions for the domains sleep duration (0.416), sleep efficiency (0.198), sleep disturbance (0.523), and sleep medications (0.915). However, significant group × time interactions were observed for global sleep score (0.022), and for the domains sleep quality (0.001), sleep latency (0.029), and daytime dysfunction (0.012). In addition, there was a significant group × time interaction for EDS (HIIT = -3.4 ± 0.9; CG change = -1.0 ± 1.0; p = 0.023). Thus, in patients with OSA, 12 weeks of HIIT improves perceived sleep quality and daytime sleepiness., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
18. Treatment of obstructive sleep apnea: To apply positive pressure, or negative pressure, that's the question.
- Author
-
Verbraecken J
- Subjects
- Humans, Sleep Apnea, Obstructive therapy, Continuous Positive Airway Pressure
- Abstract
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Johan Verbraecken reports financial support was provided by Air Liquide SA. Johan Verbraecken reports financial support was provided by Atos Medical AB. Johan Verbraecken reports financial support was provided by Bioprojet. Johan Verbraecken reports financial support was provided by Desitin Pharmaceuticals. Johan Verbraecken reports financial support was provided by Epilog. Johan Verbraecken reports was provided by Horizon 2020 European Innovation Council Fast Track to Innovation. Johan Verbraecken reports financial support was provided by Idorsia Pharmaceuticals Germany GmbH. Johan Verbraecken reports financial support was provided by Inspire Medical Systems Inc. Johan Verbraecken reports financial support was provided by Lowenstein Medical Technology LLP. Johan Verbraecken reports financial support was provided by Mediq Tefa. Johan Verbraecken reports financial support was provided by Micromed OSG. Johan Verbraecken reports financial support was provided by Philips. Johan Verbraecken reports financial support was provided by Prosomnus. Johan Verbraecken reports financial support was provided by ResMed. Johan Verbraecken reports financial support was provided by Sefam. Johan Verbraecken reports financial support was provided by SD Worx. SomnoMed reports financial support was provided by SomnoMed. Johan Verbraecken reports financial support was provided by SOS Oxygène. Johan Verbraecken reports was provided by Tilman S.A. Johan Verbraecken reports financial support was provided by Total Care. Johan Verbraecken reports financial support was provided by Ministry of the Flemish Community. Johan Verbraecken reports financial support was provided by Vivisol B. Johan Verbraecken reports financial support was provided by VLAIO. Johan Verbraecken reports financial support was provided by Vlerick Business School. Johan Verbraecken reports financial support was provided by Westfalen Medical. Johan Verbraecken reports financial support was provided by ZOLL Respicardia Inc. Johan Verbraecken reports a relationship with Universitair Ziekenhuis Antwerpen that includes: employment. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
19. Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea.
- Author
-
Jobanputra AM, Kesavarapu K, Naik S, Ramagopal M, Scharf MT, and Jagpal S
- Subjects
- Humans, Obesity complications, Cystic Fibrosis complications, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Overnutrition complications
- Abstract
Cystic fibrosis (CF) care is evolving with the ubiquitous use of modulator therapy and resultant increase in lifespan. It is important for CF clinicians to monitor the pathologic weight gain that is concomitantly being seen as obesity is a known risk factor for multiple other diseases. In this review we focus on obesity in CF, discuss screening and lifestyle considerations, outline CF-specific concerns with weight loss medications, and describe the vicious cycle of obesity and obstructive sleep apnea (OSA). We discuss screening and treatment for OSA, as it directly correlates with weight fluctuation. We offer interim recommendations for CF teams as they continue to care for this population., (© 2024 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
20. The effect and exploration of continuous positive pressure ventilation combined with upper limb robot training on upper limb function in stroke patients with OSAHS.
- Author
-
Huang D, Liu X, Wu Z, Zhuang Y, and Liu Y
- Subjects
- Humans, Middle Aged, Male, Female, Treatment Outcome, Aged, Recovery of Function, Combined Modality Therapy, Upper Extremity, Stroke Rehabilitation methods, Robotics, Stroke physiopathology, Stroke therapy, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Continuous Positive Airway Pressure
- Published
- 2024
- Full Text
- View/download PDF
21. Obstructive sleep apnea in pregnancy: A review of the literature from the obstetrics practitioner's view and a proposed clinical approach.
- Author
-
Farid S, Giunio-Zorkin M, Schust DJ, and Cortese R
- Subjects
- Humans, Pregnancy, Female, Pregnancy Outcome, Obstetrics, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Pregnancy Complications diagnosis, Pregnancy Complications therapy
- Abstract
Obstructive sleep apnea (OSA) is a frequent condition during pregnancy and its occurrence is increased in obese women. There are growing concerns about both pre-existing OSA and the development of gestational OSA and their effect on maternal pregnancy outcomes, fetal development, and even early childhood. A strong body of research has revealed maternal complications of OSA, but far fewer studies explore its impact on the developing fetus, highlighting an important area of future research. As evidence in both areas mounts about the negative reproductive impact of OSA, studies have emerged that explore the limitations of current diagnostic criteria and screening tools for this disorder in pregnancy which, in turn, limit the practitioner's ability to appropriately refer patients for OSA diagnosis and treatment. This expert review summarizes the current data regarding OSA screening tools in pregnancy, the limitations of these tools, and available OSA treatments and their efficacies. Our objective is to develop recommendations for how to best screen and manage OSA in pregnancy. We conclude that improved understanding of available tools and treatments will allow the obstetric practitioner to better counsel patients and help mitigate the deleterious effects of OSA on mother and fetus. We herein propose a clinical approach for the screening and management of OSA in pregnancy., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
22. A Protocolized Approach to Awake Endoscopy With Advanced Programming to Optimize Hypoglossal Nerve Stimulation.
- Author
-
Wesson T, Saltagi MZ, Manchanda S, Stahl S, Chernyak Y, and Parker N
- Subjects
- Humans, Middle Aged, Male, Wakefulness, Female, Treatment Outcome, Aged, Adult, Clinical Protocols, Hypoglossal Nerve, Sleep Apnea, Obstructive therapy, Electric Stimulation Therapy methods, Endoscopy methods
- Abstract
Hypoglossal nerve stimulation is a treatment option for patients with obstructive sleep apnea who are intolerant to positive airway pressure therapy. In the post-implant period, awake endoscopy with advanced programming (AEAP) can be employed to optimize apnea-hypopnea index reduction and/or patient comfort and usage. The report herein describes awake endoscopy with AEAP as a guide to providers involved in post-implant care. The first 5 consecutive patients were reviewed to provide general understanding of outcomes and safety when implementing such a protocolized approach., (© 2024 The Authors. Otolaryngology–Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology–Head and Neck Surgery Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
23. Mechanistic insights from sleep endoscopy related to oronasal mask failures: a case report.
- Author
-
Harkins TR, Seay E, Schwartz AR, Thuler E, and Dedhia RC
- Subjects
- Humans, Male, Aged, Equipment Failure, Polysomnography, Sleep Apnea, Obstructive therapy, Masks adverse effects, Endoscopy methods, Continuous Positive Airway Pressure methods
- Abstract
A 71-year-old male with severe obstructive sleep apnea and nasal septal deviation presented to a positive airway pressure (PAP) alternatives clinic due to persistent obstructive events on both continuous PAP and bilevel PAP therapy delivered via oronasal mask. He underwent drug-induced sleep endoscopy with PAP titration to determine the mechanism of oronasal mask failure. A nasal mask was also applied and titrated for comparison. Drug-induced sleep endoscopy with PAP showed tongue base collapse which resolved at low pressure using a nasal mask. Application of an oronasal mask increased minimum therapeutic PAP level. Tightening the mask worsened tongue base collapse, which was not resolved by increasing the PAP level. Following nasal surgery, the patient was able to tolerate nasal continuous PAP at low therapeutic pressure, which resulted in both objective and self-reported improvement is his obstructive sleep apnea. This case highlights the ability of drug-induced sleep endoscopy with PAP to determine the mechanistic cause of oronasal mask failure., Citation: Harkins TR, Seay E, Schwartz AR, Thuler E, Dedhia RC. Mechanistic insights from sleep endoscopy related to oronasal mask failures: a case report. J Clin Sleep Med . 2024;20(9):1551-1554., (© 2024 American Academy of Sleep Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
24. Reply: Exploring the Role of Testosterone in the Differential Outcomes of Continuous Positive Airway Pressure and Glucagon-like peptide 1 Treatments in Obstructive Sleep Apnea.
- Author
-
Ryan S and O'Donnell C
- Subjects
- Humans, Treatment Outcome, Sleep Apnea, Obstructive therapy, Continuous Positive Airway Pressure, Testosterone therapeutic use, Testosterone blood, Glucagon-Like Peptide 1
- Published
- 2024
- Full Text
- View/download PDF
25. Educational video demonstrating collapsibility of the upper airway during sleep improves initial acceptance of CPAP in patients with severe obstructive sleep apnea: a retrospective study.
- Author
-
Tselepi C, Tsirves G, Exarchos K, Chronis C, Kyriakopoulos C, Tatsis K, Kostikas K, and Konstantinidis A
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Patient Education as Topic methods, Video Recording, Patient Acceptance of Health Care statistics & numerical data, Patient Acceptance of Health Care psychology, Severity of Illness Index, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive psychology, Continuous Positive Airway Pressure methods, Polysomnography methods
- Abstract
Study Objectives: We investigated whether an audiovisual educational video demonstrating collapsibility of the upper airway during sleep would influence initial continuous positive airway pressure (CPAP) acceptance among patients with severe obstructive sleep apnea., Methods: Between January 2017 and December 2018, a single-center retrospective study was conducted. We implemented an educational video demonstrating upper airway collapsibility during sleep in February 2018. We analyzed the medical records from 145 consecutive patients diagnosed with severe obstructive sleep apnea who underwent in-laboratory polysomnography both before and after implementing the educational video. Among them, 76 patients received standard care before the video's introduction (standard care group), and another 69 patients were managed after its implementation (video group)., Results: Baseline characteristics including age, body mass index, educational level, occupation category, comorbidities, Mallampati score, Epworth Sleepiness Scale score, apnea-hypopnea index, and sleep time with SpO
2 below 90% were not significantly different between the 2 groups. Acceptance of CPAP following an in-laboratory overnight titration study was significantly higher in the video group (80%) than in the standard care group (57%) ( P = .003). Multivariate regression analyses revealed that watching the video was a strong predictor of initial CPAP acceptance (odds ratio, 4.162; 95% confidence interval, 1.627-10.646; P = .004). Both sleep time with SpO2 below 90% (odds ratio, 1.020; 95% confidence interval, 1.002-1.038; P = .029) and sleep efficiency (odds ratio, 1.052; 95% confidence interval, 1.023-1.083; P < .001) were weak predictors for initial CPAP acceptance. At 12 months, adherence among those who accepted the CPAP treatment was similar between the 2 groups (78% vs 74%; P = .662). However, within the initial cohorts, a significantly higher proportion of patients in the video group (62%) were using CPAP at 12 months compared with the standard care group (42%) ( P = .015)., Conclusions: Among patients with severe obstructive sleep apnea, an educational video demonstrating upper airway collapsibility during sleep improved initial CPAP acceptance rates when compared with standard care., Citation: Tselepi C, Tsirves G, Exarchos K, et al. Educational video demonstrating collapsibility of the upper airway during sleep improves initial acceptance of CPAP in patients with severe obstructive sleep apnea: a retrospective study. J Clin Sleep Med. 2024;20(9):1423-1433., (© 2024 American Academy of Sleep Medicine.)- Published
- 2024
- Full Text
- View/download PDF
26. Assessment and rehabilitation of tongue motor skills with myofunctional therapy in obstructive sleep apnea: a systematic review and meta-analysis.
- Author
-
Poncin W, Willemsens A, Gely L, and Contal O
- Subjects
- Humans, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Myofunctional Therapy methods, Tongue physiopathology, Motor Skills physiology
- Abstract
Study Objectives: The first objective of this study was to compare tongue motor skills between patients with obstructive sleep apnea (OSA) and healthy participants. Second, the effect of oropharyngeal myofunctional therapy (MFT) on the tongue muscular qualities of patients with OSA was evaluated., Methods: Searches were conducted in 5 electronic databases up to July 2023. Risk of bias was assessed via the Joanna Briggs Institute appraisal checklist for cross-sectional studies (aim number 1) and the Physiotherapy Evidence Database (PEDro) scale for randomized controlled trials (aim number 2). Pooled standardized mean differences and 95% confidence intervals were calculated using a random-effects model., Results: Thirteen studies including 520 adults and one study including 92 children addressed aim number 1. Compared to healthy adults, individuals with OSA had no significant difference in tongue protrusion strength (9 studies, n = 366; standardized mean difference [95% confidence interval], -0.00 [-0.45, 0.44]) or endurance (5 studies, n = 125; 0.31 [-0.26, 0.88]) but presented a lower tongue elevation strength (6 studies, n = 243; 1.00 [0.47, 1.53]) and elevation endurance (3 studies, n = 98; 0.52 [0.11, 0.94]). In children, tongue elevation strength was lower but elevation endurance was higher in those with OSA than in healthy children. Two randomized controlled trials (28 adults, 54 children) addressed aim number 2 and were of poor methodological quality. In these studies, myofunctional therapy improved tongue motor skills in patients with OSA., Conclusions: Tongue elevation motor skills are decreased in adults with OSA, whereas tongue protrusion motor skills seem preserved. Very few data are available in children. There are also too few data about the impact of myofunctional therapy on tongue motor skills., Citation: Poncin W, Willemsens A, Gely L, Contal O. Assessment and rehabilitation of tongue motor skills with myofunctional therapy in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med . 2024;20(9):1535-1549., (© 2024 American Academy of Sleep Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
27. Validity, reliability, and responsiveness of the Brazilian version of the instrument World Health Organization Disability Assessment Schedule (WHODAS 2.0) for individuals with obstructive sleep apnoea.
- Author
-
de Oliveira ACS, Zacarias LC, de Souza CCC, Bezerra JPDS, Viana-Junior AB, Sobreira-Neto MA, and Leite CF
- Subjects
- Humans, Male, Female, Brazil, Reproducibility of Results, Middle Aged, Surveys and Questionnaires, Adult, Severity of Illness Index, Aged, Polysomnography methods, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive therapy, Psychometrics instrumentation, Psychometrics methods, Disability Evaluation, World Health Organization, Continuous Positive Airway Pressure methods, Quality of Life psychology
- Abstract
Background: Obstructive sleep apnoea (OSA) is a disabling health condition, and there is no disease-specific patient-reported outcome instrument to assess individuals with OSA., Objectives: To evaluate the psychometric properties of the Brazilian version of the World Health Organization Disability Assessment Schedule (WHODAS 2.0) in individuals with OSA., Methods: One hundred individuals with OSA responded to the WHODAS 2.0 version of 36 items, the Epworth Sleepiness Scale (ESS), the Pittsburgh Sleep Quality Index (PSQI), and the 12-item health survey (SF-12). Internal consistency, convergent and discriminative validity, and responsiveness to continuous positive airway pressure (CPAP) were the psychometric properties tested., Results: Cronbach's α values indicate good internal consistency (0.91 - 0.73), except for the self-care domain (α = 0.52). Convergent validity indicated an excellent correlation (r = -0.80) between the domains of functioning and quality of life. Discriminative validity showed no association between OSA severity and functioning (p = 0.90). The responsiveness to CPAP treatment showed a large effect size (r = 0.82; p < 0.05) CONCLUSIONS: The WHODAS 2.0 instrument is valid, reliable, and responsive for assessing individuals with OSA., Competing Interests: Declaration of competing interest None., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis.
- Author
-
Malhotra A, Heilmann CR, Banerjee KK, Dunn JP, Bunck MC, and Bednarik J
- Subjects
- Humans, Body Mass Index, Weight Loss physiology, Sleep Apnea, Obstructive therapy, Obesity complications, Obesity therapy, Bariatric Surgery
- Abstract
Obstructive sleep apnea (OSA) is strongly associated with obesity. While the relationship between weight reduction and apnea-hypopnea index improvement has been documented, to our knowledge, it has not been quantified adequately. Therefore, this study aimed to quantify the relationship between weight reduction and AHI change., Methods: A systematic literature search was performed using meta-analyses (PRISMA) guidelines for studies reporting AHI and weight loss in people with obesity/overweight and OSA between 2000 and 2023. A linear and quadratic model (weighted by treatment arm sample size) predicted percent change from baseline AHI against mean percent change from baseline weight. The quadratic term was statistically significant (P < 0.05), so the quadratic model (with 95 % prediction interval) was used., Results: The literature search identified 27 studies/32 treatment arms: 15 using bariatric surgery and lifestyle intervention each and 2 using pharmacological interventions. Included studies were ≥3 months with weight intervention and participants had AHI ≥15/h. Weight reduction in people with OSA and obesity was associated with improvements in the severity of OSA. BMI reduction of 20 % was associated with AHI reduction of 57 %, while further weight reduction beyond 20 % in BMI was associated with a smaller effect on AHI. As the prediction intervals are relatively wide, a precise relationship could not be conclusively established., Conclusion: The degree of AHI index improvement was associated with the magnitude of weight reduction. The model suggests that with progress in weight reduction beyond 20 %, the incremental decrease in BMI appeared to translate to a smaller additional effect on AHI., Competing Interests: Declaration of competing interest Atul Malhotra receives funding from the NIH. He reports income related to medical education from Zoll, Livanova, Eli Lilly and Company, and Jazz. ResMed provided a philanthropic donation to UCSD. Cory R Heilmann, Julia P. Dunn, Kushal K. Banerjee, Mathijs C. Bunck, and Josef Bednarik are employees and shareholders of Eli Lilly and Company., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Burden of obstructive sleep apnea and CPAP use on patients with chronic rhinosinusitis.
- Author
-
Hunt C, Kais A, Ramadan HH, and Makary CA
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Chronic Disease, Cost of Illness, Polysomnography, Retrospective Studies, Continuous Positive Airway Pressure, Quality of Life, Rhinosinusitis complications, Rhinosinusitis therapy, Sleep Apnea, Obstructive epidemiology, Sleep Apnea, Obstructive etiology, Sleep Apnea, Obstructive therapy
- Abstract
Objective: To evaluate the impact of obstructive sleep apnea (OSA) on the quality-of-life (QoL) of patients with chronic rhinosinusitis (CRS)., Methods: Retrospective cohort study of all adult patients with CRS presenting to our rhinology clinic between August 2020 and February 2023 was performed. OSA was established based on positive polysomnography. Patients' characteristics, apnea-hypopnea index, comorbidities, endoscopy scores, and SNOT-22 scores were collected., Results: A total of 513 patients with CRS were included, 127 patients with OSA and 386 without OSA. CRS patients with OSA were older (p < 0.001), had higher BMI (p < 0.001), more likely to be males (p = 0.07), more likely to have asthma (p < 0.001), and more likely to have COPD (p = 0.001). Presence of nasal polyps did not differ between the two groups. Baseline SNOT-22 scores were worse in the OSA cohort (44.4 vs 40.5, p = 0.064) secondary to worse sleep (13.4 vs 11.1; p = 0.002) and psychological (14.2 vs 11.5; p = 0.002) domains. Worse SNOT scores were strongly associated with presence of OSA after adjusting for confounding variables, including age, gender, asthma, allergic rhinitis, nasal septal deviation, and smoking status., Conclusion: OSA is an independent negative contributor to the disease specific QoL in patients with CRS. CPAP use does not seem to affect the QoL in CRS patients with OSA. Further research is warranted to explore the impact of OSA in the outcome of medical and surgical treatment of CRS patients., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
30. Sociodemographic and Healthcare System Barriers to PAP Alternatives for Adult OSA: A Scoping Review.
- Author
-
Singh A, Bhat A, Saroya J, Chang J, and Durr ML
- Subjects
- Humans, Adult, Continuous Positive Airway Pressure statistics & numerical data, Sociodemographic Factors, Male, Female, Sleep Apnea, Obstructive therapy, Health Services Accessibility statistics & numerical data
- Abstract
Objective: To investigate sociodemographic and healthcare system barriers to access and utilization of alternative treatments to positive airway pressure (PAP) in the management of adult obstructive sleep apnea (OSA)., Data Sources: PubMed, Embase, and Web of Science databases were searched from 2003 to 2023 for English-language studies containing original data on sociodemographic and healthcare system barriers to PAP-alternative treatments for adult OSA., Review Methods: Studies were assessed using the Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines. Title and abstract screening, full-text review, and data collection were conducted by two investigators independently., Results: Out of 1,615 studies screened, 13 studies met inclusion criteria and reported on a total of 1,206,115 patients who received PAP alternative treatments, including surgery (n = 9 studies), and oral appliances (OAs) (n = 3 studies). The chance of receiving a PAP-alternative treatment such as surgery was greater among patients aged 39 years or younger, had body mass index below 30 kg/m
2 , fewer comorbidities, private insurance, and a higher occupational and income status. The decision of individuals to receive PAP alternative treatments was influenced by increased patient education from providers, as well as improvements in daytime sleepiness and partner perception of snoring and apnea., Conclusion: Cumulative evidence suggests that several sociodemographic and healthcare system factors are associated with decreased use of PAP alternatives when PAP therapy fails. Investigation of interventions to eliminate these potential barriers may improve access and treatment outcomes. Laryngoscope, 134:3903-3909, 2024., (© 2024 The American Laryngological, Rhinological and Otological Society, Inc.)- Published
- 2024
- Full Text
- View/download PDF
31. Addressing the gaps: What social media tells us about patient experiences with hypoglossal nerve stimulation.
- Author
-
Bentan MA, Moffatt D, Dawood E, and Nord R
- Subjects
- Humans, Retrospective Studies, Male, Female, Social Media, Sleep Apnea, Obstructive therapy, Hypoglossal Nerve, Electric Stimulation Therapy methods, Electric Stimulation Therapy adverse effects
- Abstract
Purpose: Hypoglossal nerve stimulation (HNS) can be an effective treatment for moderate to severe obstructive sleep apnea (OSA) in positive airway pressure (PAP) intolerant patients. To better understand patient perceptions of HNS therapy, we explored three Facebook groups pertaining to HNS therapy., Materials and Methods: A retrospective analysis of Facebook posts from three HNS-related Facebook groups, from October 1, 2022 to October 1, 2023, was performed. Posts were analyzed for author attitude, content (adverse events, inquiries, or sharing information), and the inclusion of media within the post., Results: From 737 Facebook posts, 752 events were identified, predominantly authored by patients or family (99.5 %). Few posts included media attachments (7.3 %), primarily photos (85.5 %). Post tone was mainly neutral (79.4 %), rather than positive (12.9 %) or negative (7.7 %). Most posts (53.6 %) were queries to the Facebook group, as opposed to sharing information (28.9 %) or detailing adverse events (17.6 %). Notably queries posed by Facebook group members included those pertaining to the postoperative recovery course (10.17 %), physical activity restrictions (6.20 %), HNS therapy eligibility (4.71 %), financial considerations (4.22 %), and more., Conclusion: Overall, Facebook group members reported a predominantly neutral tone, typically posting queries to the group rather than sharing information or detailing adverse events. These findings illustrate how diverse data sources, such as social media, can enhance our understanding of patient experiences and identify gaps in patient education with HNS therapy., Competing Interests: Declaration of competing interest Dr. Ryan Nord is a consultant for Inspire Medical Systems., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. DENTAL AND SKELETAL CHANGES OF LONG-TERM USE OF MANDIBULAR ADVANCEMENT DEVICES FOR THE TREATMENT OF ADULT OBSTRUCTIVE SLEEP APNEA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
- Author
-
Yu M, Ma Y, Gong XU, and Gao X
- Subjects
- Humans, Adult, Sleep Apnea, Obstructive therapy, Mandibular Advancement instrumentation
- Abstract
Background: Mandibular advancement devices (MADs) are indicated for use in patients with mild to moderate obstructive sleep apnea (OSA). Long-term use of MADs has been found to be associated with dental and skeletal changes. This study aims to conduct a systematic review and meta-analysis to improve knowledge about the dental and skeletal changes of long-term (>1 year) use of MADs for the treatment of OSA., Material and Methods: Electronic databases were systematically searched. Two reviewers conducted screening, quality assessment, and data extraction independently. Thirty-four studies were included in the systematic review and 23 in the meta-analysis., Results: The mean change of overjet and overbite was -0.77mm (95%CI -1.01 to -0.53, P < .00001) and -0.64mm (95%CI -0.85 to -0.43, P < .00001), with progressive change over the treatment duration. The inclination of the upper incisor (U1/SN) and the lower incisor (L1/MP) showed a mean change of retroclined -2.10° (95%CI -3.93 to -0.28, P = .02) and proclined 1.78° (95%CI 0.63 to 2.92, P = .002), respectively. The mean change of the anteroposterior position of the mandible (SNB) was -0.33° posteriorly (95%CI -0.65 to -0.02, P = .04)., Conclusions: The meta-analysis showed a gradual decrease in overjet and overbite with treatment duration with long-term use of MADs for the treatment of OSA. Upper and lower incisors retroclined and proclined, respectively. The skeletal changes might include the mandibular position. Patients treated with MADs need to be continuously monitored over time., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
33. Evaluation of the efficacy of a custom-made monoblock mandibular advancement device in treatment of obstructive sleep apnea hypopnea syndrome.
- Author
-
Guichaoua C, Dugast S, Derrien A, Boudaud P, Chaux AG, Bertin H, and Corre P
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Treatment Outcome, Adult, Aged, Equipment Design, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive diagnosis, Mandibular Advancement instrumentation, Mandibular Advancement methods
- Abstract
Introduction: Mandibular advancement devices (MAD) are an alternative to continuous positive airway pressure for the treatment of obstructive sleep apnea hypopnea syndrome (OSAHS). We aimed to evaluate the efficiency of a custom-made monoblock MAD for the treatment of OSAHS., Materials and Methods: We carried out a monocentric retrospective observational study including patients with OSAHS (mild, moderate or severe) or isolated ronchopathy from January 2005 to March 2023. The primary objective was to evaluate the overall efficiency of the MAD assessed by the percentage of patients successfully treated. The secondary objectives included the global efficiency of the device in the treatment of snoring, the report of side effects, and the identification of predictive factors for efficacy or failure., Results: The medical records of 586 patients were collected, and 293 patients (229 OSAHS and 64 isolated ronchopathy) were included in the analysis. After a mean 2.9 years follow-up, 72.5 % of patients were successfully treated by MAD. We observed a significant improvement in ronchopathy, both in terms of intensity and percentage of time per night. Regarding patients with isolated ronchopathy, 87.5 % reported an improvement in their symptoms and satisfaction with their treatment. Finally, 14.0 % of the patients declared side-effects, the dentoskeletal modifications being the most frequent (6.1 % of the patients)., Conclusion: This study confirmed the long-term efficacy and good tolerance of a custom-made monoblock orthosis in OSAHS., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
34. Obstructive Sleep Apnea and Mental Health Disorders in the Pediatric Population: A Retrospective, Population-based Cohort Study.
- Author
-
Kendzerska T, Radhakrishnan D, Amin R, Narang I, Boafo A, Robillard R, Talarico R, Blinder H, Spitale N, and Katz SL
- Subjects
- Humans, Male, Retrospective Studies, Female, Child, Child, Preschool, Adolescent, Ontario epidemiology, Infant, Longitudinal Studies, Infant, Newborn, Tonsillectomy, Adenoidectomy, Propensity Score, Proportional Hazards Models, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive epidemiology, Polysomnography, Mental Disorders epidemiology, Mental Disorders therapy
- Abstract
Rationale: Information is limited about the association between obstructive sleep apnea (OSA) and mental health disorders in children. Objectives: In children, 1 ) to evaluate the association between OSA and new mental healthcare encounters; and 2 ) to compare mental healthcare encounters 2 years after to 2 years before OSA treatment initiation. Methods: We conducted a retrospective longitudinal cohort study using Ontario health administrative data (Canada). Children (0-18 yr) who underwent diagnostic polysomnography (PSG) 2009-2016 and met criteria for definition of moderate-severe OSA (PSG-OSA) were propensity score weighted by baseline characteristics and compared with children who underwent PSG in the same period but did not meet the OSA definition (PSG-No-OSA). Children were followed until March 2021. Weighted cause-specific Cox proportional hazards and modified Poisson regression models were used to compare time from PSG to first mental healthcare encounter and frequency of new mental healthcare encounters per person time, respectively. Among those who underwent adenotonsillectomy (AT) or were prescribed and claimed positive airway pressure therapy (PAP), we used age-adjusted conditional logistic regression models to compare 2 years post-treatment to pretreatment odds of mental healthcare encounters. Results: Of 32,791 children analyzed, 7,724 (23.6%) children met criteria for moderate-severe OSA. In the PSG-OSA group, 7,080 (91.7%) were treated (AT or PAP). Compared with PSG-No-OSA, the PSG-OSA group had a shorter time from PSG to first mental healthcare encounter (hazard ratio, 1.08; 95% confidence interval [CI], 1.05-1.12) but less frequent mental healthcare encounters in follow-up (rate ratio, 0.92; 95% CI, 0.87-0.97). OSA treatment (AT or PAP) was associated with lower odds of mental healthcare encounters 2 years after treatment initiation compared with 2 years before (odds ratio, 0.69; 95% CI, 0.65-0.74). Conclusions: In this large, population-based study of children who underwent PSG for sleep disorder assessment, OSA diagnosis/treatment was associated with an improvement in some mental health indicators, such as fewer new mental healthcare encounters compared with no OSA and lower odds of mental healthcare encounters compared with before OSA treatment.
- Published
- 2024
- Full Text
- View/download PDF
35. Combination of acute intermittent hypoxia and intermittent transcutaneous electrical stimulation in obstructive sleep apnea: a randomized controlled crossover trial.
- Author
-
Zha S, Liu X, Chen H, Hao Y, Zhang J, Zhang Q, and Hu K
- Subjects
- Humans, Male, Middle Aged, Female, Adult, Treatment Outcome, Polysomnography, Combined Modality Therapy, Prospective Studies, Severity of Illness Index, Aged, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Cross-Over Studies, Transcutaneous Electric Nerve Stimulation methods, Hypoxia therapy, Hypoxia physiopathology
- Abstract
Intermittent hypoxia (IH) and intermittent transcutaneous electrical stimulation (ITES) might benefit patients with obstructive sleep apnea (OSA). However, the therapeutic value of combined IH and ITES in OSA is unknown. In this prospective, randomized, controlled crossover study, normoxia (air exposure for 50 min before sleep and sham stimulation for 6 h during sleep), IH (5 repeats of 5 min 10-12 % O
2 alternating with 5 min air for 50 min, and sham stimulation for 6 h), ITES (air exposure for 50 min and 6 repeats of 30 min transcutaneous electrical stimulation alternating with 30 min of sham stimulation for 6 h), and IH&ITES (10-12 % O2 alternating with air for 50 min and transcutaneous electrical stimulation alternating with sham stimulation for 6 h) were administered to patients with OSA over four single-night sessions. The primary endpoint was difference in OSA severity between the interventions according to apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). The efficacy was response to IH, ITES, IH&ITES defined as a ≥50 % reduction in AHI compared with normoxia. Twenty participants (17 male, 3 female) completed the trial. The median (IQR) AHI decreased from 14.5 (10.8, 17.5) events/h with normoxia to 6.9 (3.9, 14.8) events/h with IH (p=0.020), 5.7 (3.4, 9.1) events/h with ITES (p=0.001), and 3.5 (1.8, 6.4) events/h with IH&ITES (p=0.001). AHI was significantly different between IH and IH&ITES (p=0.042) but not between ITES and IH&ITES (p=0.850). For mild-moderate OSA (n=17), IH, ITES, and IH&ITES had a significant effect on AHI (p=0.013, p=0.001, p=0.001, respectively) compared with normoxia, but there were no differences in post hoc pairwise comparisons between intervention groups. No serious adverse events were observed. In conclusion, IH, ITES, and IH&ITES significantly reduced OSA severity. IH&ITES showed better efficacy in mild-moderate OSA than IH and was comparable to ITES. Our data do not support recommending IH&ITES over ITES for OSA., Competing Interests: Declaration of Competing Interest The authors have no relevant disclosures., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
36. The Cost-Effectiveness of Sleep Apnea Management: A Critical Evaluation of the Impact of Therapy on Health Care Costs.
- Author
-
Pendharkar SR, Kaambwa B, and Kapur VK
- Subjects
- Humans, Continuous Positive Airway Pressure economics, Continuous Positive Airway Pressure methods, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive economics, Sleep Apnea Syndromes therapy, Sleep Apnea Syndromes economics, Cost-Benefit Analysis, Health Care Costs statistics & numerical data, Quality of Life
- Abstract
Topic Importance: OSA is a widespread condition that significantly affects both health and health-related quality of life (HRQoL). If left untreated, OSA can lead to accidents, decreased productivity, and medical complications, resulting in significant economic burdens including the direct costs of managing the disorder. Given the constraints on health care resources, understanding the cost-effectiveness of OSA management is crucial. A key factor in cost-effectiveness is whether OSA therapies reduce medical costs associated with OSA-related complications., Review Findings: Treatments for OSA have been shown to enhance HRQoL, particularly for symptomatic patients with moderate or severe disease. Economic studies also have demonstrated that these treatments are highly cost-effective. However, although substantial empirical evidence shows that untreated OSA is associated with increased medical costs, uncertainty remains about the impact of OSA treatment on these costs. Randomized controlled trials of positive airway pressure (PAP) therapy have failed to demonstrate cost reductions, but the studies have had important limitations. Observational studies suggest that PAP therapy may temper increases in costs, but only among patients who are highly adherent to treatment. However, the healthy adherer effect is an important potential source of bias in these studies., Summary: OSA management is cost-effective, although uncertainties persist regarding the therapy's impact on medical costs. Future studies should focus on reducing bias, particularly the healthy adherer effect, and addressing other confounding factors to clarify potential medical cost savings. Promising avenues to further understanding include using quasiexperimental designs, incorporating more sophisticated characterization of OSA severity and symptoms, and leveraging newer technologies (eg, big data, wearables, and artificial intelligence)., Competing Interests: Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: S. R. P. reports honoraria, consultancy fees, or both from Jazz Pharmaceuticals, Paladin Labs, and the International Centre for Professional Development in Health and Medicine and sponsorship funding from Jazz Pharmaceuticals. B. K. reports consultancy fees from Novartis Vaccines and Diagnostics AG. V. K. K. reports that at the time of this publication, he is a board member of the American Academy of Sleep Medicine, but contributed to this article in his personal capacity. The views expressed are his own and do not necessarily represent the views of the American Academy of Sleep Medicine., (Copyright © 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
37. Differences in Positive Airway Pressure Requirements in Obstructive Sleep Apnea Between Black and White Patients.
- Author
-
Cai Y, Parekh MH, Rodin J, Tangutur A, Yu JL, Keenan BT, Schwartz AR, and Dedhia RC
- Subjects
- Humans, Male, Female, Middle Aged, Cross-Sectional Studies, Adult, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive ethnology, Sleep Apnea, Obstructive physiopathology, White People, Continuous Positive Airway Pressure, Black or African American
- Abstract
Objective: There are disparities between Black and White patients in the utilization of positive airway pressure (PAP) alternatives for obstructive sleep apnea (OSA). Given low utilization rates among Black patients, there is limited knowledge of PAP alternative outcomes in this group. Therapeutic PAP levels are clinically accessible measures that have been shown to predict PAP alternative outcomes. Herein, we examined differences in PAP requirements between Black and White patients in a large clinical sample., Study Design: Cross-sectional., Setting: Academic sleep center., Methods: We included OSA patients prescribed autoadjusting PAP between January 2018 and 2020 with baseline apnea-hypopnea index (AHI) ≥ 10. Mean and 90th percentile PAP levels were compared between White and Black patients who used PAP for ≥1 hour daily using linear regression controlling for age, sex, body mass index (BMI), AHI, oxygen saturation nadir, and mask type., Results: There were 157 Black and 234 White patients who were generally obese (BMI, 37.3 ± 8.7) with severe OSA (AHI, 36.9 ± 25.6). Black patients had a 0.68 cm higher (95% confidence interval [CI]: 0.36, 1.35) mean PAP level and 0.85 cm H
2 O higher (95% CI: 0.36, 1.35) 90th percentile PAP level than white patients. Although statistically significant, differences were small and not clinically meaningful., Conclusion: Black and White OSA patients had clinically insignificant differences in PAP requirements, suggesting comparable upper airway collapsibility. Considering the predictive value of therapeutic PAP levels, our findings suggest Black and White patients may have comparable PAP alternative responses from a collapsibility standpoint. Future studies should explore reasons for low utilization of PAP alternatives among Black patients., (© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.)- Published
- 2024
- Full Text
- View/download PDF
38. Obstructive Sleep Apnea and Serotoninergic Signalling Pathway: Pathomechanism and Therapeutic Potential.
- Author
-
Witkowska A, Jaromirska J, Gabryelska A, and Sochal M
- Subjects
- Humans, Animals, Receptors, Serotonin metabolism, Sleep Apnea, Obstructive metabolism, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Sleep Apnea, Obstructive physiopathology, Serotonin metabolism, Signal Transduction
- Abstract
Obstructive Sleep Apnea (OSA) is a disorder characterized by repeated upper airway collapse during sleep, leading to apneas and/or hypopneas, with associated symptoms like intermittent hypoxia and sleep fragmentation. One of the agents contributing to OSA occurrence and development seems to be serotonin (5-HT). Currently, the research focuses on establishing and interlinking OSA pathogenesis and the severity of the disease on the molecular neurotransmitter omnipresent in the human body-serotonin, its pathway, products, receptors, drugs affecting the levels of serotonin, or genetic predisposition. The 5-HT system is associated with numerous physiological processes such as digestion, circulation, sleep, respiration, and muscle tone-all of which are considered factors promoting and influencing the course of OSA because of correlations with comorbid conditions. Comorbidities include obesity, physiological and behavioral disorders as well as cardiovascular diseases. Additionally, both serotonin imbalance and OSA are connected with psychiatric comorbidities, such as depression, anxiety, or cognitive dysfunction. Pharmacological agents that target 5-HT receptors have shown varying degrees of efficacy in reducing the Apnea-Hypopnea Index and improving OSA symptoms. The potential role of the 5-HT signaling pathway in modulating OSA provides a promising avenue for new therapeutic interventions that could accompany the primary treatment of OSA-continuous positive airway pressure. Thus, this review aims to elucidate the complex role of 5-HT and its regulatory mechanisms in OSA pathophysiology, evaluating its potential as a therapeutic target. We also summarize the relationship between 5-HT signaling and various physiological functions, as well as its correlations with comorbid conditions.
- Published
- 2024
- Full Text
- View/download PDF
39. Clinical Effect of Personalized Adjustable Mandibular Advancement Device on Obstructive Sleep Apnea.
- Author
-
Wang W, Pang J, Zhang YX, Mo YM, Zhang J, and Wei ZH
- Subjects
- Humans, Male, Middle Aged, Female, Adult, Treatment Outcome, Cone-Beam Computed Tomography, Temporomandibular Joint physiopathology, Sleep Apnea, Obstructive therapy, Mandibular Advancement instrumentation, Polysomnography
- Abstract
Aims/Background: Mandibular advancement devices are effective in treating mild or moderate obstructive sleep apnea (OSA), but such devices that are commonly used in clinical settings require further improvement. In this study, we evaluated the clinical effects of personalized adjustable mandibular advancement devices on mild or moderate OSA. Methods: Forty patients with mild or moderate OSA were randomly divided into experimental (personalized adjustable device) and control (traditional device) groups. Side effects, including increased salivation, dry mouth, muscle aches, and temporomandibular joint discomfort, were assessed. Respiratory markers during sleep, including the apnea-hypopnea index, mean blood oxygen saturation, lowest blood oxygen saturation and maximum apnea time, were evaluated using polysomnography. The upper airway cross-sectional area and temporomandibular joint morphology and motion trajectory were evaluated using cone beam computed tomography. Results: Side effects were significantly lower in the experimental group than in the control group. Respiratory marker levels were significantly restored post-treatment. Soft palate- and tongue-pharyngeal cross-sectional areas were significantly increased in both groups, but temporomandibular joint morphology or motion trajectory remained unchanged. Conclusion: The personalized adjustable mandibular advancement devices may reduce side effects and are effective in treating patients with OSA. Clinical Trial Registration: The study was registered and approved by the Chinese Clinical Trial Registry (ChiCTR2400080306). https://www.chictr.org.cn/showproj.html?proj=206538.
- Published
- 2024
- Full Text
- View/download PDF
40. Longer-term impacts of the COVID-19 pandemic on obstructive sleep apnoea (OSA)-related healthcare: a province-based study.
- Author
-
Kendzerska T, Povitz M, Gershon AS, Ryan CM, Talarico R, Saymeh M, Robillard R, Ayas NT, and Pendharkar SR
- Subjects
- Humans, Ontario epidemiology, Retrospective Studies, Male, Female, Middle Aged, Adult, SARS-CoV-2, Aged, Continuous Positive Airway Pressure, Ambulatory Care statistics & numerical data, Pandemics, Delivery of Health Care, COVID-19 epidemiology, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive epidemiology, Polysomnography
- Abstract
Rationale: Following marked reductions in sleep medicine care early in the COVID-19 pandemic, there is limited information about the recovery of these services. We explored long-term trends in obstructive sleep apnoea (OSA) health services and service backlogs during the pandemic compared with pre-pandemic levels in Ontario (the most populous province of Canada)., Methods: In this retrospective population-based study using Ontario (Canada) health administrative data on adults, we compared rates of polysomnograms (PSGs), outpatient visits and positive airway pressure (PAP) therapy purchase claims during the pandemic (March 2020 to December 2022) to pre-pandemic rates (2015-2019). We calculated projected rates using monthly seasonal time series auto-regressive integrated moving-average models based on similar periods in previous years. Service backlogs were estimated from the difference between projected and observed rates., Results: Compared with historical data, all service rates decreased at first during March to May 2020 and subsequently increased. By December 2022, observed service rates per 100 000 persons remained lower than projected for PSGs (September to December 2022: 113 vs 141, 95% CI: 121 to 163) and PAP claims (September to December 2022: 50 vs 60, 95% CI: 51 to 70), and returned to projected for outpatient OSA visits. By December 2022, the service backlog was 193 078 PSGs (95% CI: 139 294 to 253 075) and 57 321 PAP claims (95% CI: 27 703 to 86 938)., Conclusion: As of December 2022, there was a sustained reduction in OSA-related health services in Ontario, Canada. The resulting service backlog has likely worsened existing problems with underdiagnosis and undertreatment of OSA and supports the adoption of flexible care delivery models for OSA that include portable technologies., Competing Interests: Competing interests: All authors declare they have no potential conflict of interest. TK and ASG are supported by the PSI (Physicians' Services Incorporated) foundation. Outside of the submitted work, SP has received honoraria from Jazz Pharmaceuticals, Paladin Labs and the International Centre for Professional Development in Health and Medicine for participation in educational activities and grant funding from Jazz Pharmaceuticals. RR received honoraria from Eisai and Boehringer Ingelheim Pharma GmbH & Co., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
41. Predictors of Positive Airway Pressure Therapy Adherence Among U.S. Active Duty Military Personnel With Obstructive Sleep Apnea.
- Author
-
Shaha DP, Ee JS, Pham CK, Choi LS, Dogbey GY, and Pogorzelski N
- Subjects
- Humans, Male, Female, Adult, Retrospective Studies, Cross-Sectional Studies, United States epidemiology, Middle Aged, Surveys and Questionnaires, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive psychology, Military Personnel psychology, Military Personnel statistics & numerical data, Continuous Positive Airway Pressure psychology, Continuous Positive Airway Pressure statistics & numerical data, Continuous Positive Airway Pressure methods, Patient Compliance statistics & numerical data, Patient Compliance psychology
- Abstract
Introduction: Obstructive sleep apnea (OSA) is prevalent among U.S. military personnel, but adherence to positive airway pressure (PAP) treatment is suboptimal. This study sought to identify factors that predict the adherence to PAP therapy of active duty military patients newly diagnosed with OSA., Materials and Methods: The study was a retrospective cross-sectional analysis of 239 active duty military patients (94% men, mean age 40.0 ± 7.8 years), who were admitted into PAP therapy and participated in a single 90-minute behavioral intervention session. The session included a self-assessment of sleep trouble, sleep distress, impact of sleep on functioning, emotional difficulty from sleep, stress appraisal, and beliefs about OSA and PAP. PAP usage data of the patients were analyzed at 30-, 60-, and 180 days post-intervention using descriptive statistics and multivariable linear regression analysis., Results: Positive airway pressure adherence of at least 4 hours nightly usage decreased slightly over the course of the study; mean number of days used over a 30-day timeframe at the 30-, 60-, and 180-day mark were 15.6, 14.9, and 14.1 days, respectively. On nights used, PAP usage remained consistent at 4.8 to 5.0 hours over the 30-, 60-, and 180-day mark. Age, apnea-hypopnea index, readiness, self-efficacy or confidence in treatment implementation, and worries about sleep were statistically significant predictors of adherence. Furthermore, worries about sleep negatively affected PAP usage hours on nights used, regardless of meeting adherence criterion, in the early phase of treatment and in the long run at the 180-day mark., Conclusions: Readiness for therapy, self-efficacy, confidence in putting into action the treatment plan, and worries about sleep are modifiable variables that may be targeted in programs to boost PAP adherence and usage among the military population. Future studies should explore the predictive aspects of each of these variables and identify interventions to improve them., (© The Association of Military Surgeons of the United States 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
42. Behavioral KSA Intervention Class to Boost Positive Airway Pressure Adherence Among Active Duty Military Personnel With Obstructive Sleep Apnea.
- Author
-
Ee JS, Pham CK, Shaha DP, Mounts CW, Dogbey GY, and Pogorzelski N
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Behavior Therapy methods, Behavior Therapy statistics & numerical data, Behavior Therapy standards, Body Mass Index, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive psychology, Sleep Apnea, Obstructive complications, Military Personnel statistics & numerical data, Military Personnel psychology, Patient Compliance statistics & numerical data, Patient Compliance psychology, Continuous Positive Airway Pressure methods, Continuous Positive Airway Pressure statistics & numerical data, Continuous Positive Airway Pressure psychology
- Abstract
Introduction: Obstructive sleep apnea (OSA) is a treatable cause of daytime sleepiness and associated medical problems that can negatively impact soldier readiness and performance. This study examined adherence to positive airway pressure (PAP) by soldiers who were newly diagnosed with OSA and prescribed PAP therapy and participated in a Knowledge, Skills, and Attitudes (KSA) behavioral intervention class., Materials and Methods: The KSA was a one-time, interactive 90-minute class attended by up to 10 patients per class. PAP adherence was examined using Medicare standard at 30-, 60-, 90-, and 180 days post class. The analytic sample comprised 379 active duty patients (93% men; mean age 40.21 ± 8.06) categorized into 3 groups: KSA (n = 235), did not show (DNS; n = 61), and mandatory education class (MEC; n = 83). The MEC group comprised patients from an education class in a previous year., Results: Baseline scores on the apnea hypopnea index, body mass index, sleepiness, insomnia severity, and age were non-significant among the 3 groups. At 30 days, significantly more patients in KSA (48%) and MEC (51%) were adherent than the DNS group (16%). At 60 days, the adherence rates for the KSA, DNS, and MEC were significantly different at 39%, 22%, and 27%, respectively. At 90- and 180 days, the adherence rates among the KSA, DNS, and MEC groups did not differ significantly at 34%, 17%, and 26% (90 days) and 34%, 27%, and 25% (180 days), respectively. Consistently, more patients in KSA were adherent than those in DNS and MEC, except at 30 days. Additionally, adherence rates for KSA intervention declined more gradually over the 6 month period. The mean PAP usage on nights used was 4.6 hours that computed to a 34% non-use rate based on an optimal 7-hour/night sleep time., Conclusion: KSA could be a behavioral intervention that enhances PAP adherence with a booster session implemented at the 90 days mark., (© The Association of Military Surgeons of the United States 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
43. Pediatric obstructive sleep apnea: diagnosis and management.
- Author
-
Xavier LF, Barros PB, Azevedo SPDC, Pinto LA, and Lumertz MS
- Subjects
- Humans, Child, Polysomnography, Continuous Positive Airway Pressure, Sleep Apnea, Obstructive diagnosis, Sleep Apnea, Obstructive therapy
- Published
- 2024
- Full Text
- View/download PDF
44. Effect of Time-Restricted Eating on Sleep in Type 2 Diabetes.
- Author
-
Pavlou V, Lin S, Cienfuegos S, Ezpeleta M, Runchey MC, Corapi S, Gabel K, Kalam F, Alexandria SJ, Vidmar AP, and Varady KA
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Sleep Quality, Time Factors, Adult, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Sleep Initiation and Maintenance Disorders etiology, Diabetes Mellitus, Type 2 complications, Caloric Restriction, Sleep physiology
- Abstract
The aim of this secondary analysis was to compare the effects of time-restricted eating (TRE) versus calorie restriction (CR) and controls on sleep in adults with type 2 diabetes (T2D). Adults with T2D (n = 75) were randomized to 1 of 3 interventions for 6 months: 8 h TRE (eating only between 12 and 8 pm daily); CR (25% energy restriction daily); or control. Our results show that TRE has no effect on sleep quality, duration, insomnia severity, or risk of obstructive sleep apnea, relative to CR and controls, in patients with T2D over 6 months.
- Published
- 2024
- Full Text
- View/download PDF
45. [Novel advances in assessment and treatment of obstructive sleep apnea].
- Author
-
Qiu Y and Wang W
- Subjects
- Humans, Continuous Positive Airway Pressure methods, Mandibular Advancement methods, Mandibular Advancement instrumentation, Polysomnography, Severity of Illness Index, Oxygen Saturation, Sleep Apnea, Obstructive therapy
- Abstract
The current indicators for assessing obstructive sleep apnea are sleep apnea-hypopnea index (AHI) and the lowest nocturnal oxygen saturation, but they do not comprehensively reflect the severity of the disease. The main treatments for OSA are continuous positive airway pressure, mandibular advancement devices and surgery, which have poor compliance and limited effectiveness. Therefore, there is a need to explore novel methods to assess and treat OSA. This article systematically summarized recent advances in this field.
- Published
- 2024
- Full Text
- View/download PDF
46. Effects of different treatments for obstructive sleep apnea on temporomandibular joint: a randomized clinical trial.
- Author
-
Attia AAMM, Awad SS, Mansour M, Baz H, Zahran KM, and Saleh AM
- Subjects
- Humans, Adult, Female, Male, Middle Aged, Prospective Studies, Myofunctional Therapy methods, Young Adult, Temporomandibular Joint diagnostic imaging, Magnetic Resonance Imaging, Polysomnography, Treatment Outcome, Pain Measurement, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive complications, Mandibular Advancement instrumentation, Mandibular Advancement methods, Continuous Positive Airway Pressure, Temporomandibular Joint Disorders therapy, Temporomandibular Joint Disorders complications, Temporomandibular Joint Disorders diagnostic imaging
- Abstract
Background: In recent years, obstructive sleep apnea (OSA) has been increasingly recognized as a significant health concern. No previous studies assessed the effect of recommended treatment modalities of patients with OSA on the temporomandibular joint (TMJ). The current study aimed to evaluate the effect of different treatment modalities of OSA, such as continuous positive airway pressure (CPAP), mandibular advancement device (MAD), and oral myofunctional therapy (OMT) on subjective symptoms, clinical, and radiographic signs of temporomandibular disorders., Patients & Methods: This hospital-based prospective randomized controlled clinical trial study was approved by the institutional review board and formal patient consent, 39 OSA patients, ranging in age from 19 to 56 after confirmation with full night Polysomnography (PSG) with healthy TMJ confirmed clinically and radiographically with magnetic resonance imaging (MRI) were randomly allocated into three treatment groups. Group 1: 13 patients were managed with CPAP after titration, group 2: 13 patients were managed with digitally fabricated MAD, and group 3: 13 patients were managed with OMT. The following parameters were evaluated before and 3 months after the intervention. Pain using a visual analogue scale (VAS), maximum inter-incisal opening (MIO), lateral movements, and clicking sound of TMJ. MRI was done before and 3 months after the intervention., Results: Out of the 83 patients enrolled, 39 patients completed the treatment. There were no statistically significant differences in lateral jaw movements or clicking, and no significant difference in MRI findings between the three studied groups before and after the intervention. The OMT group showed a statistically significant difference in pain (p = 0.001), and MIO (p = 0.043) where patients experienced mild pain and slight limitation in mouth opening after 3 months of follow-up in comparison to MAD and CPAP groups., Conclusion: CPAP and MAD are better for preserving the health of TMJ in the treatment of OSA patients. While OMT showed mild pain and slight limitation of MIO (that is still within the normal range of mouth opening) compared to CPAP and MAD., Trial Registration: The study was listed on www., Clinicaltrials: gov with registration number (NCT05510882) on 22/08/2022., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
47. Long-term effect of obstructive sleep apnoea management on blood pressure in patients with resistant hypertension: the SARAH study.
- Author
-
Torres G, Sánchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, Martinez D, Dalmases M, Pinilla L, Minguez O, Vaca R, Pascual L, Aguilá M, Cortijo A, Gort C, Martinez-Garcia MÁ, Mediano O, Romero Peralta S, Fortuna-Gutierrez AM, Ponte Marquez P, Drager LF, Cabrini M, de Barros S, Masa JF, Corral Peñafiel J, Felez M, Vázquez S, Abad J, García-Rio F, Casitas R, Lee CH, and Barbé F
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Prospective Studies, Antihypertensive Agents therapeutic use, Polysomnography, Continuous Positive Airway Pressure, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive complications, Hypertension complications, Hypertension physiopathology, Blood Pressure, Blood Pressure Monitoring, Ambulatory
- Abstract
Background: There is a close relationship between obstructive sleep apnoea (OSA) and resistant hypertension (RH). However, studies assessing the long-term effect of diagnosing and treating OSA on blood pressure (BP) control in these patients are lacking., Methods: To address this gap, we recruited 478 RH patients from hypertension units and followed them prospectively after they were screened for OSA through a sleep study. By performing 24-h ambulatory BP monitoring (ABPM) annually, the effect of OSA management was assessed., Results: The patients had a median (interquartile range (IQR)) age of 64.0 (57.2-69.0) years, 67% were males and most were nonsleepy, with a median (IQR) apnoea-hypopnoea index (AHI) of 15.8 (7.9-30.7) events·h
-1 . The median (IQR) follow-up time was 3.01 (2.93-3.12) years. At baseline, severe OSA was associated with uncontrolled BP, nocturnal hypertension and a nondipper circadian BP pattern. Moreover, these patients had higher BP values during follow-up than did patients in the other groups. However, among patients with moderate and severe OSA, the management of sleep disordered breathing, including the implementation of continuous positive airway pressure treatment, was associated with a reduction in 24-h ABPM parameters, especially night-time BP values, at the 1-year follow-up. These benefits were attenuated over time and only subjects with severe OSA maintained an ABPM night-time reduction at 3 years. Furthermore, clinical variables such as uncontrolled BP, sex and age showed a predictive value for the BP response at 1 year of follow-up., Conclusion: A favourable long-term decrease in BP was detected by diagnosing and treating OSA in a cohort of RH patients from hypertension units, but over time this decrease was only partially maintained in severe OSA patients., Competing Interests: Conflict of interest: F. Barbé received research grants from Philips Respironics Inc. and ResMed (companies that develop products related to sleep apnoea), the Health Research Fund, the Spanish Ministry of Health, and the Spanish Respiratory Society to develop the SARAH study. Philips Respironics Inc. and ResMed partly funded the SARAH study but did not participate in nor were they involved in decisions regarding study development or the present manuscript. The remaining authors declare no competing interests., (Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.)- Published
- 2024
- Full Text
- View/download PDF
48. Determinants of physical activity in newly diagnosed obstructive sleep apnea patients: testing the health action process approach.
- Author
-
Latrille C, Hayot M, Bosselut G, Bughin F, and Boiché J
- Subjects
- Humans, Male, Female, Middle Aged, Longitudinal Studies, Adult, Health Behavior, Aged, Sleep Apnea, Obstructive psychology, Sleep Apnea, Obstructive therapy, Sleep Apnea, Obstructive diagnosis, Self Efficacy, Exercise psychology, Motivation, Intention, Social Support
- Abstract
This study aims to identify the determinants associated with physical activity (PA) behavior in newly diagnosed obstructive sleep apnea (OSA) patients by applying the Health Action Process Approach (HAPA) with a longitudinal design. Anthropometric and clinical (OSA severity, subjective somnolence, use of continuous positive airway pressure (CPAP)) variables, the determinants of physical activity specified in the HAPA (motivational self-efficacy, outcome expectancies, risk perception, intention, maintenance self-efficacy, action planning, coping planning, social support), as well as physical activity behavior were assessed using a longitudinal (T1 and T2) design in a sample of 57 OSA patients in routine care. Applying regression analyses, regarding the motivation phase, the amount of explained variance in intention was 77% and 39% of the variance in physical activity. In the motivational phase, motivational self-efficacy, risk perception and outcome expectancies were associated with intention. In the volitional phase, physical activity at T1 and social support (family) were related with physical activity at T2. In conclusion, the assumptions of HAPA were partially found in the context of newly diagnosed OSA patients. This study provided additional evidence regarding the role of motivational self-efficacy, outcome expectancies and risk perception during motivational phase, and highlighted the important role of social support from the family in the PA in this population., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
49. Troubleshooting Upper Airway Stimulation Therapy Using Drug-Induced Sleep Endoscopy.
- Author
-
Kaffenberger TM, Plawecki A, Kaki P, Boon M, and Huntley C
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Adult, Treatment Outcome, Polysomnography, Aged, Sleep, Sleep Apnea, Obstructive therapy, Endoscopy methods, Electric Stimulation Therapy methods
- Abstract
Objective: This study assesses the utility of drug-induced sleep endoscopy (DISE) in guiding further treatment for patients with obstructive sleep apnea (OSA) who have difficulty tolerating upper airway stimulation (UAS) or have inadequate response to therapy., Study Design: We conducted a retrospective analysis of UAS patients at our institution who underwent DISE, post-UAS, and evaluated the efficacy of different electrode configurations and maneuvers., Setting: A tertiary care hospital., Methods: Out of 379 patients who received UAS therapy, 34 patients who underwent DISE post-UAS (DISE-UAS) were included. Palatal coupling (PC) was assessed with UAS stimulation alone, jaw thrust alone, and both simultaneously during DISE., Results: Among 34 patients, 5 had suboptimal adherence to UAS therapy, 19 had suboptimal therapy efficacy with residual OSA burden, and 10 had both. During DISE-UAS, PC was observed in 7 patients (21%) with UAS stimulation alone, 9 patients (26%) with jaw thrust alone, and 8 patients (24%) with both maneuvers combined. Notably, 10 patients (29%) did not exhibit PC with any maneuver. Based on DISE-UAS findings, 13 patients were recommended oral appliance therapy (OAT), and 8 patients underwent further surgical interventions., Conclusion: DISE-UAS is a valuable adjunct in troubleshooting UAS therapy for patients intolerant to CPAP or with suboptimal therapy efficacy. This study provides an algorithm for targeted multimodality therapy based on DISE findings, facilitating personalized management approaches., (© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
50. Impacts of conservative treatment on the clinical manifestations of obstructive sleep apnea-systematic review and meta-analysis.
- Author
-
Costa IOM, Cunha MO, Bussi MT, Cassetari AJ, Zancanella E, and Bagarollo MF
- Subjects
- Humans, Continuous Positive Airway Pressure, Sleep Apnea, Obstructive therapy, Conservative Treatment
- Abstract
Introduction: Obstructive sleep apnea (OSA) is a chronic disease with a high populational prevalence that is characterized as airway closure during sleep. Treatment is multidisciplinary and varies according to each case. Continuous positive airway pressure (CPAP), oral appliances, and surgery are the primary therapeutic options. Non-invasive conservative treatments such as sleep hygiene, positional therapy, physical exercises, and weight loss aim to reduce the worsening of the disease while being complementary to the invasive primary treatment., Objective: To analyze the impact of non-invasive conservative therapies on the clinical manifestations of OSA syndrome (OSA), compared with other interventions., Method: This was a systematic review with meta-analysis. The searches were performed without filters for the time period, type of publication, or language. Randomized clinical trials on subjects over 18 years of age diagnosed with untreated OSA were included. Responses to non-invasive conservative treatment were compared with responses to the primary intervention. Primary outcomes were assessed using the Epworth Sleepiness Scale and/or Functional Outcomes of Sleep Questionnaire (FOSQ)., Results: A total of eight studies were included in the review. The heterogeneity of the effect was estimated at 89.77%. Six studies compared conservative treatment with CPAP, one with oral appliances, and one with oropharyngeal exercises. Using the Epworth Sleepiness Scale measurements, the standardized difference in the estimated means, based on the random-effects model, was 0.457 (95% CI (1.082 to 0.169)) and the mean result did not differ significantly from zero (z = 1.43; p = 0.153). The conservative therapies assessed in this study improved the subjective quality of sleep, although the post-treatment ESE scores did not show significant results. The reduction in AHI and better outcomes in the evaluated domains, as well as in cognition and mood, were superior in the groups that received CPAP and IOD., Conclusion: The most commonly used treatments of choice for OSA are invasive, including the use of CPAP, oral appliances, and surgeries, being the most utilized options. This study demonstrated that non-invasive conservative treatments, such as sleep hygiene, yield results as effective as invasive treatments. Further studies are needed to confirm this result and to predict whether invasive treatment can be used as the primary treatment or only as a supplement., (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.